Review



mcp 1  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems mcp 1
    Mcp 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 102 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+ccl2/bio_rxiv__64898__2026__02__21__707190-359-9-11?v=R%26D+Systems
    Average 95 stars, based on 102 article reviews
    mcp 1 - by Bioz Stars, 2026-07
    95/100 stars

    Images



    Similar Products

    94
    MedChemExpress recombinant human ccl2 mcp 1
    Recombinant Human Ccl2 Mcp 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+ccl2/pm41318049-102-22-26?v=MedChemExpress
    Average 94 stars, based on 1 article reviews
    recombinant human ccl2 mcp 1 - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    93
    Sino Biological recombinant human mcp
    Recombinant Human Mcp, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+ccl2/10__3390_slash_ijms262210850-175-12-16?v=Sino+Biological
    Average 93 stars, based on 1 article reviews
    recombinant human mcp - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    95
    R&D Systems mcp 1
    Mcp 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+ccl2/bio_rxiv__64898__2026__02__21__707190-359-9-11?v=R%26D+Systems
    Average 95 stars, based on 1 article reviews
    mcp 1 - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    93
    Proteintech mcp
    Mcp, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+ccl2/pm41645729-374-11-16?v=Proteintech
    Average 93 stars, based on 1 article reviews
    mcp - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    95
    R&D Systems recombinant human ccl2
    Production of <t>CCL2</t> quantified by ELISA assay in SCAP conditioned medium (CM-SCAP). Bars show the mean and standard deviation of the experiment (N=3) (A). Viability of monocytes stimulated with decreasing dilutions of SCAP supernatant (CM) compared with control (proliferation medium alone). Absorbance (570nm) data obtained from the MTT assay after 24 h of stimulus exposure (B). Fluorescence data obtained by Alamar Blue assay at experimental time of 24 h. Conditioned medium by SCAP (CM-SCAP) diluted ½ in the presence or not of a CCL2 neutralizer (CM-SCAP + α-CCL2) compared to control (proliferation medium alone) and <t>Recombinant</t> <t>Human</t> <t>CCL2</t> (CCL2 rH) (C). The result showed the mean and standard deviation of the experiments performed in triplicate. Different letters represent statistical differences between groups. (One-Way ANOVA with Tukey's test, p<0.05) (B and C).
    Recombinant Human Ccl2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+ccl2/pmc12815457-55-3-7?v=R%26D+Systems
    Average 95 stars, based on 1 article reviews
    recombinant human ccl2 - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    95
    R&D Systems human ccl2
    a. 125 <t>I-CCL2</t> Pe in the presence of 10 µg/mL CCL2 compared to PBS vehicle. b. 131 I-Alb Pe in the presence of 10 µg/mL CCL2 compared to PBS vehicle. c. 125 I-CCL2 Pe corrected for non-specific leakage as quantified by 131 I-Alb Pe in the presence 10 µg/mL CCL2 compared to PBS vehicle. a-c. One differentiation was performed with n = 7-8 transwells per group. **p < 0.01, ***p < 0.001 (Unpaired two-tailed t-test). Means are displayed with their SD.
    Human Ccl2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+ccl2/pmc12698020-52-10-12?v=R%26D+Systems
    Average 95 stars, based on 1 article reviews
    human ccl2 - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    95
    R&D Systems monocyte chemotactic protein 1
    a. 125 <t>I-CCL2</t> Pe in the presence of 10 µg/mL CCL2 compared to PBS vehicle. b. 131 I-Alb Pe in the presence of 10 µg/mL CCL2 compared to PBS vehicle. c. 125 I-CCL2 Pe corrected for non-specific leakage as quantified by 131 I-Alb Pe in the presence 10 µg/mL CCL2 compared to PBS vehicle. a-c. One differentiation was performed with n = 7-8 transwells per group. **p < 0.01, ***p < 0.001 (Unpaired two-tailed t-test). Means are displayed with their SD.
    Monocyte Chemotactic Protein 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+ccl2/bio_rxiv__2025__11__07__687176-119-11-14?v=R%26D+Systems
    Average 95 stars, based on 1 article reviews
    monocyte chemotactic protein 1 - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    95
    R&D Systems recombinant human ccl2 je mcp 1
    a. 125 <t>I-CCL2</t> Pe in the presence of 10 µg/mL CCL2 compared to PBS vehicle. b. 131 I-Alb Pe in the presence of 10 µg/mL CCL2 compared to PBS vehicle. c. 125 I-CCL2 Pe corrected for non-specific leakage as quantified by 131 I-Alb Pe in the presence 10 µg/mL CCL2 compared to PBS vehicle. a-c. One differentiation was performed with n = 7-8 transwells per group. **p < 0.01, ***p < 0.001 (Unpaired two-tailed t-test). Means are displayed with their SD.
    Recombinant Human Ccl2 Je Mcp 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+ccl2/pm41160815-479-5-11?v=R%26D+Systems
    Average 95 stars, based on 1 article reviews
    recombinant human ccl2 je mcp 1 - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    Image Search Results


    Production of CCL2 quantified by ELISA assay in SCAP conditioned medium (CM-SCAP). Bars show the mean and standard deviation of the experiment (N=3) (A). Viability of monocytes stimulated with decreasing dilutions of SCAP supernatant (CM) compared with control (proliferation medium alone). Absorbance (570nm) data obtained from the MTT assay after 24 h of stimulus exposure (B). Fluorescence data obtained by Alamar Blue assay at experimental time of 24 h. Conditioned medium by SCAP (CM-SCAP) diluted ½ in the presence or not of a CCL2 neutralizer (CM-SCAP + α-CCL2) compared to control (proliferation medium alone) and Recombinant Human CCL2 (CCL2 rH) (C). The result showed the mean and standard deviation of the experiments performed in triplicate. Different letters represent statistical differences between groups. (One-Way ANOVA with Tukey's test, p<0.05) (B and C).

    Journal: Brazilian Dental Journal

    Article Title: Chemoattractive potential of stem cells from apical papilla in peripheral blood monocytes: an in vitro study

    doi: 10.1590/0103-644020256694

    Figure Lengend Snippet: Production of CCL2 quantified by ELISA assay in SCAP conditioned medium (CM-SCAP). Bars show the mean and standard deviation of the experiment (N=3) (A). Viability of monocytes stimulated with decreasing dilutions of SCAP supernatant (CM) compared with control (proliferation medium alone). Absorbance (570nm) data obtained from the MTT assay after 24 h of stimulus exposure (B). Fluorescence data obtained by Alamar Blue assay at experimental time of 24 h. Conditioned medium by SCAP (CM-SCAP) diluted ½ in the presence or not of a CCL2 neutralizer (CM-SCAP + α-CCL2) compared to control (proliferation medium alone) and Recombinant Human CCL2 (CCL2 rH) (C). The result showed the mean and standard deviation of the experiments performed in triplicate. Different letters represent statistical differences between groups. (One-Way ANOVA with Tukey's test, p<0.05) (B and C).

    Article Snippet: 300 ng/ml of Recombinant Human CCL2 (279-MC-010 R&D Systems) was used for positive control, while α-MEM 10% was the negative control.

    Techniques: Enzyme-linked Immunosorbent Assay, Standard Deviation, Control, MTT Assay, Fluorescence, Alamar Blue Assay, Recombinant

    a. 125 I-CCL2 Pe in the presence of 10 µg/mL CCL2 compared to PBS vehicle. b. 131 I-Alb Pe in the presence of 10 µg/mL CCL2 compared to PBS vehicle. c. 125 I-CCL2 Pe corrected for non-specific leakage as quantified by 131 I-Alb Pe in the presence 10 µg/mL CCL2 compared to PBS vehicle. a-c. One differentiation was performed with n = 7-8 transwells per group. **p < 0.01, ***p < 0.001 (Unpaired two-tailed t-test). Means are displayed with their SD.

    Journal: PLOS One

    Article Title: Transport of CCL2 across an induced pluripotent stem cell-derived in vitro model of the human blood-brain barrier is heparan sulfate-dependent

    doi: 10.1371/journal.pone.0338780

    Figure Lengend Snippet: a. 125 I-CCL2 Pe in the presence of 10 µg/mL CCL2 compared to PBS vehicle. b. 131 I-Alb Pe in the presence of 10 µg/mL CCL2 compared to PBS vehicle. c. 125 I-CCL2 Pe corrected for non-specific leakage as quantified by 131 I-Alb Pe in the presence 10 µg/mL CCL2 compared to PBS vehicle. a-c. One differentiation was performed with n = 7-8 transwells per group. **p < 0.01, ***p < 0.001 (Unpaired two-tailed t-test). Means are displayed with their SD.

    Article Snippet: The chloramine-T method was used to radioactively label recombinant carrier-free human CCL2 (R & D Systems, 279-MC-050/CF) with 125 I and bovine serum albumin (BSA, Sigma cat no. 17030-100G) with 131 I, as described previously [ ].

    Techniques: Two Tailed Test

    a. 125 I-CCL2 Pe in the presence of 20 U/mL heparin or 10 µM RS504393 (CCR2 antagonist) compared to control (“Ctrl”). b. 131 I-Alb Pe in the presence of 20 U/mL heparin or 10 µM RS504393 compared to an untreated control group. c. 125 I-CCL2 Pe corrected for non-specific leakage as quantified by 131 I-Alb Pe in the presence of 20 U/mL heparin or 10 µM RS504393 compared to an untreated control group. a-c. ***p < 0.001, ****p < 0.0001 (One-way ANOVA with Tukey’s multiple comparisons test). d. Comparison of 125 I-CCL2 and 131 I-Alb Pe in the untreated control group. ****p < 0.0001 (Unpaired two-tailed t-test). a-d. One differentiation was performed with n = 5-6 transwells per group. Means are displayed with their SD.

    Journal: PLOS One

    Article Title: Transport of CCL2 across an induced pluripotent stem cell-derived in vitro model of the human blood-brain barrier is heparan sulfate-dependent

    doi: 10.1371/journal.pone.0338780

    Figure Lengend Snippet: a. 125 I-CCL2 Pe in the presence of 20 U/mL heparin or 10 µM RS504393 (CCR2 antagonist) compared to control (“Ctrl”). b. 131 I-Alb Pe in the presence of 20 U/mL heparin or 10 µM RS504393 compared to an untreated control group. c. 125 I-CCL2 Pe corrected for non-specific leakage as quantified by 131 I-Alb Pe in the presence of 20 U/mL heparin or 10 µM RS504393 compared to an untreated control group. a-c. ***p < 0.001, ****p < 0.0001 (One-way ANOVA with Tukey’s multiple comparisons test). d. Comparison of 125 I-CCL2 and 131 I-Alb Pe in the untreated control group. ****p < 0.0001 (Unpaired two-tailed t-test). a-d. One differentiation was performed with n = 5-6 transwells per group. Means are displayed with their SD.

    Article Snippet: The chloramine-T method was used to radioactively label recombinant carrier-free human CCL2 (R & D Systems, 279-MC-050/CF) with 125 I and bovine serum albumin (BSA, Sigma cat no. 17030-100G) with 131 I, as described previously [ ].

    Techniques: Control, Comparison, Two Tailed Test

    a. Representative immunocytochemistry of Heparan Sulfate clone F58-10E4 (HS(10E4)) (red) and DAPI (blue) in vehicle or HSase I, II, and III-treated iBECs. b-c. Immunofluorescence analysis of HS(10E4) mean fluorescence intensities (MFI) relative to DAPI area (b) or total HS(10E4) area relative to DAPI area (c). d-e. 125 I-CCL2 (d) or 131 I-Alb in the presence of 0.25 U/ml HSase I, II, and III compared to vehicle. f. 125 I-CCL2 Pe corrected for non-specific leakage as quantified by 131 I-Alb Pe in the presence of 0.25 U/ml HSase I, II, and III compared to vehicle. One differentiation was performed with n = 7-8 transwells per group. *p < 0.05, ***p < 0.001 (Unpaired two-tailed t-test). Means are displayed with their SD. Figure created with BioRender.

    Journal: PLOS One

    Article Title: Transport of CCL2 across an induced pluripotent stem cell-derived in vitro model of the human blood-brain barrier is heparan sulfate-dependent

    doi: 10.1371/journal.pone.0338780

    Figure Lengend Snippet: a. Representative immunocytochemistry of Heparan Sulfate clone F58-10E4 (HS(10E4)) (red) and DAPI (blue) in vehicle or HSase I, II, and III-treated iBECs. b-c. Immunofluorescence analysis of HS(10E4) mean fluorescence intensities (MFI) relative to DAPI area (b) or total HS(10E4) area relative to DAPI area (c). d-e. 125 I-CCL2 (d) or 131 I-Alb in the presence of 0.25 U/ml HSase I, II, and III compared to vehicle. f. 125 I-CCL2 Pe corrected for non-specific leakage as quantified by 131 I-Alb Pe in the presence of 0.25 U/ml HSase I, II, and III compared to vehicle. One differentiation was performed with n = 7-8 transwells per group. *p < 0.05, ***p < 0.001 (Unpaired two-tailed t-test). Means are displayed with their SD. Figure created with BioRender.

    Article Snippet: The chloramine-T method was used to radioactively label recombinant carrier-free human CCL2 (R & D Systems, 279-MC-050/CF) with 125 I and bovine serum albumin (BSA, Sigma cat no. 17030-100G) with 131 I, as described previously [ ].

    Techniques: Immunocytochemistry, Immunofluorescence, Fluorescence, Two Tailed Test

    a. Molecular structure of GalNAz. b. On day 3 post-subculture, transwells were organized into treatment groups such that TEER means were approximately equal and treated with GalNAz or DMSO (vehicle control).Transwells were re-treated on day 6 post-subculture, and the effects on TEER (c), 125 I-CCL2 Pe (d) and 131 I-Alb Pe (e) were measured on day 9 post-subculture. f. For each transwell, 125 I-CCL2 Pe was corrected for non-specific leakage as quantified by 131 I-Alb Pe. b-f. **p < 0.01, ***p < 0.001 (Unpaired two-tailed t-test). One differentiation was performed with n = 9 transwells treated per group. Means are displayed with their SD. Figure created with BioRender.

    Journal: PLOS One

    Article Title: Transport of CCL2 across an induced pluripotent stem cell-derived in vitro model of the human blood-brain barrier is heparan sulfate-dependent

    doi: 10.1371/journal.pone.0338780

    Figure Lengend Snippet: a. Molecular structure of GalNAz. b. On day 3 post-subculture, transwells were organized into treatment groups such that TEER means were approximately equal and treated with GalNAz or DMSO (vehicle control).Transwells were re-treated on day 6 post-subculture, and the effects on TEER (c), 125 I-CCL2 Pe (d) and 131 I-Alb Pe (e) were measured on day 9 post-subculture. f. For each transwell, 125 I-CCL2 Pe was corrected for non-specific leakage as quantified by 131 I-Alb Pe. b-f. **p < 0.01, ***p < 0.001 (Unpaired two-tailed t-test). One differentiation was performed with n = 9 transwells treated per group. Means are displayed with their SD. Figure created with BioRender.

    Article Snippet: The chloramine-T method was used to radioactively label recombinant carrier-free human CCL2 (R & D Systems, 279-MC-050/CF) with 125 I and bovine serum albumin (BSA, Sigma cat no. 17030-100G) with 131 I, as described previously [ ].

    Techniques: Control, Two Tailed Test